A Prospective Evaluation of the GreenLight Model 120 Laser

Exclusion Criteria

• •1. Unstable cardiopulmonary disorder, previously or recently diagnosed by standard methods.
• •2. Subjects with a recent myocardial infarction or coronary artery stent placement.
• •3. Subjects with systemic diseases that cause significant neurogenic lower urinary dysfunction.
• •4. Subjects who have had major pelvic fractures that involved damage to the external urinary sphincter.
• •5. Subjects who have recently completed definitive radiation therapy for prostate cancer.
• •6. Subjects with prostate cancer who are considering brachytherapy (radioactive seed implantation) or cryotherapy as part of their definitive treatment.
• •7. Subjects must not have active localized or systemic infections; including active urinary tract infection.
• •8. Subjects with confirmed atonic bladders and/or neurogenic bladders, reflex dyssynergia, detrusor hyporeflexia/areflexia.
• •9. Subjects diagnosed with active urethral strictures, bladder neck contracture, acute prostatitis affecting bladder function.
• •10. Serum prostate specific antigen level \> 4 ng/ml, requiring prostate needle biopsy, and resultant positive pathology for malignancy of the prostate.
• •11. Subjects with confirmed or suspected malignancy of the prostate or bladder.
• •12. Subjects with renal ectasia by renal ultrasound.
• •13. Immunocompromised subjects and deemed unfit for laser vaporization as determined by the attending physician.
• •14. Any disorder or conditions of the subject that the investigator believes will contraindicate their inclusion in the study.
• •15. Subjects who refuse to sign the Informed Consent document and/or comply with all follow-up requirements.